Skip to content
healthcare.dev
Get a free key

YERVOY

NDC 0003-2327, ipilimumab, injection, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-2327
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125377
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2327 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IPILIMUMAB5 mg/mL

Pharmacologic classes

CTLA-4-directed Antibody Interactions [MoA]; CTLA-4-directed Blocking Antibody [EPC]; Increased T Lymphocyte Activation [PE]

Package NDCNDC-11Package
0003-2327-11000032327111 VIAL, SINGLE-USE in 1 CARTON (0003-2327-11) / 10 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2265ef30-253e-11df-8a39-0800200c9a66

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0003-2327

Use it

Look up 0003-2327 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2327 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-2327. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.